Yahoo
BSE - Delayed Quote INR

Akums Drugs and Pharmaceuticals Limited (AKUMS.BO)

731.50 -0.40 (-0.05%)
At close: November 2 at 3:52:23 PM GMT+5:30
AKUMS.BO Q2 2027 earnings call
Today at 12:00 PM GMT+5:30
View in AlphaSpace Currency in INR All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
3/31/2026
3/31/2025
3/31/2024
3/31/2023
Total Revenue
43,939,050
42,513,080
40,710,930
40,196,820
34,747,640
Cost of Revenue
26,117,170
25,482,100
24,657,370
25,822,240
23,074,700
Gross Profit
17,821,880
17,030,980
16,053,560
14,374,580
11,672,940
Operating Expense
13,666,540
13,291,270
12,947,050
10,775,590
9,759,800
Operating Income
4,155,340
3,739,710
3,106,510
3,598,990
1,913,140
Net Non Operating Interest Income Expense
139,830
156,040
-96,140
-386,150
-383,660
Pretax Income
4,256,920
3,821,010
3,452,530
-452,780
1,502,970
Tax Provision
1,330,020
1,257,040
14,760
-460,680
524,800
Net Income Common Stockholders
2,917,230
2,551,880
3,381,760
-40,350
948,550
Diluted NI Available to Com Stockholders
2,917,230
2,551,880
3,381,760
-40,350
948,550
Basic EPS
19.05
16.67
22.60
-0.28
6.03
Diluted EPS
19.05
16.67
22.60
-0.28
6.03
Basic Average Shares
153,152.77
153,102.06
149,609.49
144,107.14
157,394
Diluted Average Shares
153,152.77
153,102.06
149,609.49
157,394
157,394
Rent Expense Supplemental
--
13,860
20,350
59,770
34,760
Total Expenses
39,783,710
38,773,370
37,604,420
36,597,830
32,834,500
Net Income from Continuing & Discontinued Operation
2,917,230
2,551,880
3,381,760
-40,350
948,550
Normalized Income
3,055,677.65
2,686,996.37
3,142,337.95
2,660,677
1,118,922.89
Interest Income
--
1,096,770
249,860
119,990
78,800
Interest Expense
902,430
886,220
304,070
502,510
459,730
Net Interest Income
139,830
156,040
-96,140
-386,150
-383,660
EBIT
5,159,350
4,707,230
3,756,600
49,730
1,962,700
EBITDA
6,746,310
6,252,740
5,291,060
1,306,130
3,090,790
Reconciled Cost of Revenue
26,117,170
25,482,100
24,657,370
25,822,240
23,074,700
Reconciled Depreciation
1,586,960
1,545,510
1,534,460
1,256,400
1,128,090
Net Income from Continuing Operation Net Minority Interest
2,917,230
2,551,880
3,381,760
-40,350
948,550
Total Unusual Items Excluding Goodwill
-201,360
-201,360
240,450
-3,858,610
-261,780
Total Unusual Items
-201,360
-201,360
240,450
-3,858,610
-261,780
Normalized EBITDA
6,947,670
6,454,100
5,050,610
5,164,740
3,352,570
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-62,912.35
-66,243.63
1,027.95
-1,157,583
-91,407.11
3/31/2023 - 8/6/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: